NanJing Pharmaceutical Company Limited announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 21,896.767 million compared to CNY 18,272.213 million a year ago. Operating income was CNY 379.464 million compared to CNY 308.718 million a year ago. Net income was CNY 222.358 million compared to CNY 172.695 million a year ago. Basic earnings per share from continuing operations was CNY 0.213 compared to CNY 0.166 a year ago.